Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

NCT00049296 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Cancer

Interventions

DRUG: docetaxel
DRUG: thalidomide

Sponsor

Case Comprehensive Cancer Center

Collaborators

[object Object]